Published 1 year ago

Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa

Summary by Ground News

EVA Pharma expects to begin distribution of the African-made insulin products within 18 months and to reach one million people per year by 2030. This collaboration is part of the Lilly 30x30 initiative, which aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually.

0 Articles

All

Left

Center

Right

Medical Dialogues

Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa

Indianapolis: Eli Lilly and Company and EVA Pharma have announced a collaboration to deliver a sustainable supply of high-quality, affordable human and analogue insulin to at least one million people...

1 year ago·New Delhi, India

Read Full Article

africa-newsroom.com

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa

1 year ago

Read Full Article

pharmiweb.com

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa

Eli Lilly and Company (NYSE: LLY) and EVA Pharma announced today a collaboration to deliver a sustainable supply of high-quality, affordable human and analogue insulin to at least one million people living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), most of which are in Africa. In ...

1 year ago

Read Full Article

lilly.com

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa | Eli Lilly and Company

The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated1 year agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa

0 Articles

0 Articles

Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa

Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa | Eli Lilly and Company

Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa | Eli Lilly and Company

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics